Craig Hallum Issues Positive Forecast for Myomo (NYSEAMERICAN:MYO) Stock Price

Myomo (NYSEAMERICAN:MYO) had its price target lifted by Craig Hallum from $9.00 to $11.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have a buy rating on the stock.

Other equities research analysts have also recently issued research reports about the stock. Ascendiant Capital Markets upped their price objective on shares of Myomo from $8.50 to $9.00 and gave the stock a “buy” rating in a research report on Tuesday, November 12th. HC Wainwright reissued a “buy” rating and set a $7.50 target price on shares of Myomo in a research note on Wednesday, November 13th.

Myomo Price Performance

Shares of Myomo stock opened at $5.87 on Tuesday. The stock has a market capitalization of $177.57 million, a PE ratio of -25.52 and a beta of 1.68. Myomo has a 52-week low of $2.51 and a 52-week high of $7.17.

Hedge Funds Weigh In On Myomo

A number of institutional investors and hedge funds have recently modified their holdings of the business. Barclays PLC bought a new position in shares of Myomo in the 3rd quarter worth $36,000. Jane Street Group LLC bought a new position in shares of Myomo in the 3rd quarter worth $65,000. GSA Capital Partners LLP lifted its holdings in shares of Myomo by 60.8% in the 3rd quarter. GSA Capital Partners LLP now owns 103,342 shares of the company’s stock worth $414,000 after purchasing an additional 39,085 shares in the last quarter. Calamos Advisors LLC bought a new position in shares of Myomo in the 4th quarter worth $189,000. Finally, Stonepine Capital Management LLC bought a new position in shares of Myomo in the 3rd quarter worth $401,000. 44.99% of the stock is currently owned by institutional investors.

About Myomo

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.